rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1994-4-1
|
pubmed:abstractText |
Because the effects of interferon in the presence and absence of cirrhosis are still debated in chronic active hepatitis type non-A, non-B, C (NANB/C), the aim of this study was to determine to what extent the presence of cirrhosis influences the response to interferon.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0016-5085
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
686-90
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7907073-Aged,
pubmed-meshheading:7907073-Alanine Transaminase,
pubmed-meshheading:7907073-Alkaline Phosphatase,
pubmed-meshheading:7907073-Female,
pubmed-meshheading:7907073-Hepatitis C,
pubmed-meshheading:7907073-Humans,
pubmed-meshheading:7907073-Interferon-alpha,
pubmed-meshheading:7907073-Liver Cirrhosis,
pubmed-meshheading:7907073-Male,
pubmed-meshheading:7907073-Middle Aged,
pubmed-meshheading:7907073-Recurrence,
pubmed-meshheading:7907073-Sex Characteristics,
pubmed-meshheading:7907073-Time Factors,
pubmed-meshheading:7907073-gamma-Glutamyltransferase
|
pubmed:year |
1994
|
pubmed:articleTitle |
Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C.
|
pubmed:affiliation |
Département d'Hépatologie, CHU Henri Mondor, Créteil, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|